Revenue: The sum of all revenue fields included for a company's operating activities.
Krystal Biotech, Inc. (KRYS) had Revenue of $290.51M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$290.51M |
$89.16M |
|
$20.06M |
|
$270.45M |
|
$224.82M |
|
$65.69M |
|
$29.66M |
|
$95.36M |
|
$95.36M |
|
$89.16M |
|
$89.16M |
|
$89.16M |
|
$89.16M |
|
$65.69M |
|
$72.41M |
|
28.59M |
|
29.74M |
|
$3.12 |
|
$3.00 |
|
| Balance Sheet Financials | |
$742.04M |
|
$155.17M |
|
$313.79M |
|
$1.06B |
|
$102.00M |
|
-- |
|
$7.46M |
|
$109.46M |
|
$946.38M |
|
$946.38M |
|
$946.38M |
|
28.79M |
|
| Cash Flow Statement Financials | |
$123.42M |
|
$-163.44M |
|
$27.01M |
|
$358.33M |
|
$344.87M |
|
$-13.46M |
|
$49.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
93.09% |
|
22.61% |
|
22.61% |
|
24.92% |
|
32.82% |
|
30.69% |
|
$119.18M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
0.76 |
|
2.77 |
|
131.60 |
|
9.42% |
|
9.42% |
|
8.44% |
|
9.42% |
|
$32.87 |
|
$4.01 |
|
$4.15 |
|